Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Entasis Therapeutics Holdings Inc (ETTX)

2.73   0.02 (0.74%) 06-03 16:00
Open: 2.71 Pre. Close: 2.71
High: 2.81 Low: 2.71
Volume: 15,582 Market Cap: 40M
Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant gram-negative bacteria in the United States. It is involved in developing ETX2514SUL, a novel IV antibiotic that has completed Phase II clinical trial for the treatment of multi-drug resistant Acinetobacter infections; Zoliflodacin, an oral antibiotic monotherapy that has completed Phase II clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and NBPs that are in pre-clinical stage for the treatment of multidrug-resistant Gram-negative infections. The company has collaboration agreements with Zai Lab (Shanghai) Co., Ltd. for developing ETX2514SUL. Entasis Therapeutics Holdings Inc. was incorporated in 2018 and is based in Waltham, Mass

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.813 - 2.824 2.824 - 2.832
Low: 2.682 - 2.695 2.695 - 2.706
Close: 2.711 - 2.731 2.731 - 2.747

Technical analysis

as of: 2020-06-03 4:29:04 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.33     One year: 3.89
Support: Support1: 2.52    Support2: 2.31
Resistance: Resistance1: 2.85    Resistance2: 3.33
Pivot: 2.57
Moving Average: MA(5): 2.73     MA(20): 2.61
MA(100): 3.66     MA(250): 5.08
MACD: MACD(12,26): -0.02     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 75.31     %D(3): 77.79
RSI: RSI(14): 52.56
52-week: High: 9.25  Low: 1.75  Change(%): -55.4
Average Vol(K): 3-Month: 3362  10-Days: 3487

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ETTX has closed below upper band by 21.4%. Bollinger Bands are 52.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ETTX's normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 07 May 2020
Entasis Therapeutics Reports First Quarter 2020 Financial Results and Business Update - GlobeNewswire

Fri, 29 May 2020
Market's View on Entasis Therapeutics Holdings Inc (ETTX) Stock's Price & Volume Trends - InvestorsObserver

Mon, 18 May 2020
Analysts Suggest Buying These 2 Falling Knives - Yahoo Finance

Wed, 22 Apr 2020
Entasis Therapeutics Completes Initial Closing of $35M Private Placement with Innoviva - GlobeNewswire

Thu, 14 Nov 2019
Entasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update - GlobeNewswire

Fri, 13 Mar 2020
Analysts Have Been Trimming Their Entasis Therapeutics Holdings Inc. Price Target After Its Latest Report - Simply Wall St

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  NA
Industry:  NA
Shares Out. (M) 15
Shares Float (M) 3
% Held by Insiders 24.01
% Held by Institutions 65.04
Shares Short (K) 6
Shares Short P. Month (K) 4

Stock Financials

EPS -3.498
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.080
Profit Margin
Operating Margin -687.83
Return on Assets (ttm) -51.9
Return on Equity (ttm) -94.0
Qtrly Rev. Growth
Gross Profit (p.s.) 0.479
Sales Per Share 0.479
EBITDA (p.s.) -3.286
Qtrly Earnings Growth
Operating Cash Flow (M) -48
Levered Free Cash Flow (M) -32

Stock Valuations

PE Ratio -0.78
PEG Ratio
Price to Book value 1.31
Price to Sales 5.70
Price to Cash Flow -0.84

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.